Group
Anti-EGFR mAb
The data below refer to patients treated with Anti-EGFR mAb as the sole drug class,
excluding any concurrent use of drugs from other groups.
Combination therapy data are available in the section below.
Treated site
Individual Drugs
Select a drug to view its individual evidence base (drug + SBRT, no other concurrent systemic drugs). Drugs without available data are shown greyed out.